Your browser doesn't support javascript.
loading
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
Dowell, Alexander C; Butler, Megan S; Jinks, Elizabeth; Tut, Gokhan; Lancaster, Tara; Sylla, Panagiota; Begum, Jusnara; Bruton, Rachel; Pearce, Hayden; Verma, Kriti; Logan, Nicola; Tyson, Grace; Spalkova, Eliska; Margielewska-Davies, Sandra; Taylor, Graham S; Syrimi, Eleni; Baawuah, Frances; Beckmann, Joanne; Okike, Ifeanyichukwu O; Ahmad, Shazaad; Garstang, Joanna; Brent, Andrew J; Brent, Bernadette; Ireland, Georgina; Aiano, Felicity; Amin-Chowdhury, Zahin; Jones, Samuel; Borrow, Ray; Linley, Ezra; Wright, John; Azad, Rafaq; Waiblinger, Dagmar; Davis, Chris; Thomson, Emma C; Palmarini, Massimo; Willett, Brian J; Barclay, Wendy S; Poh, John; Amirthalingam, Gayatri; Brown, Kevin E; Ramsay, Mary E; Zuo, Jianmin; Moss, Paul; Ladhani, Shamez.
Afiliação
  • Dowell AC; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Butler MS; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Jinks E; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Tut G; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Lancaster T; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Sylla P; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Begum J; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Bruton R; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Pearce H; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Verma K; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Logan N; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Tyson G; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Spalkova E; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Margielewska-Davies S; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Taylor GS; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Syrimi E; Institute of Immunology & Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Baawuah F; Public Health England, 61 Colindale Avenue, London, UK.
  • Beckmann J; East London NHS Foundation Trust, London, UK.
  • Okike IO; Public Health England, 61 Colindale Avenue, London, UK.
  • Ahmad S; University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
  • Garstang J; Manchester University NHS Foundation Trust, Manchester, UK.
  • Brent AJ; Birmingham Community Healthcare NHS Trust, Aston, UK.
  • Brent B; Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
  • Ireland G; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Aiano F; University of Oxford, Wellington Square, Oxford, UK.
  • Amin-Chowdhury Z; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Jones S; Public Health England, 61 Colindale Avenue, London, UK.
  • Borrow R; Public Health England, 61 Colindale Avenue, London, UK.
  • Linley E; Public Health England, 61 Colindale Avenue, London, UK.
  • Wright J; Public Health England, 61 Colindale Avenue, London, UK.
  • Azad R; Public Health England, Manchester Royal Infirmary, Manchester, UK.
  • Waiblinger D; Public Health England, Manchester Royal Infirmary, Manchester, UK.
  • Davis C; Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
  • Thomson EC; Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
  • Palmarini M; Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
  • Willett BJ; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Barclay WS; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Poh J; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Amirthalingam G; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • Brown KE; Department of Infectious Disease, Imperial College, London, UK.
  • Ramsay ME; Public Health England, 61 Colindale Avenue, London, UK.
  • Zuo J; Public Health England, 61 Colindale Avenue, London, UK.
  • Moss P; Public Health England, 61 Colindale Avenue, London, UK.
  • Ladhani S; Public Health England, 61 Colindale Avenue, London, UK.
Nat Immunol ; 23(1): 40-49, 2022 01.
Article em En | MEDLINE | ID: mdl-34937928

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coronavirus Humano 229E / Coronavirus Humano OC43 / Proteção Cruzada / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / Anticorpos Antivirais Limite: Adult / Child / Child, preschool / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Coronavirus Humano 229E / Coronavirus Humano OC43 / Proteção Cruzada / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / Anticorpos Antivirais Limite: Adult / Child / Child, preschool / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article